Loading...
Case Commentary: Imipenem/Cilastatin and Fosfomycin for Refractory Methicillin-Resistant Staphylococcus aureus Infection: a Novel Combination Therapy
Given that it is unlikely that randomized clinical trials will yield answers for treating the most challenging bacteremic infections caused by methicillin-resistant Staphylococcus aureus, clinicians, microbiologists, and pharmacists will have to cooperate to discover novel ways to select successful...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7927839/ https://ncbi.nlm.nih.gov/pubmed/33020155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02039-20 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|